Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Whittemore G, Tingley"'
Autor:
Amos Baruch, Robert Kahn, Andrew S. Peterson, Cecilia P.C. Chiu, Whittemore G. Tingley, Nageshwar Budha, Daniel Kirchhofer, Kyra J. Cowan, Yan Wu, Diana Luca, Maya Leabman, John C. Davis
Publikováno v:
Clinical Cardiology. 40:503-511
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) downregulates low-density lipoprotein (LDL) receptors, thereby leading to a rise in circulating LDL cholesterol (LDL-C). RG7652 is a fully human monoclonal antibody against PCSK9. This
Autor:
John C. Davis, Kun Peng, Thomas Gelzleichter, Laura Pascasio Harris, Alexandr Vilimovskij, Whittemore G. Tingley, Robert Kahn, Sofia Mosesova, Kyra J. Cowan, John D. Davis, Nageshwar Budha, Amos Baruch, Josh Lehrer
Publikováno v:
The American journal of cardiology. 119(10)
RG7652 (MPSK3169A), a fully human immunoglobulin G1 (IgG1) monoclonal antibody directed against proprotein convertase subtilisin/kexin type 9 (PCSK9), blocks the interaction between PCSK9 and low-density lipoprotein (LDL) receptor. EQUATOR (ClinicalT
Autor:
Thomas Gelzleichter, Laura Pascasio Harris, Kun Peng, Sofia Mosesova, Josh Lehrer, Kyra J. Cowan, Alexandr Vilimovskij, John D. Davis, Amos Baruch, Whittemore G. Tingley, Nageshwar Budha, Robert Kahn, John C. Davis
Publikováno v:
The American Journal of Cardiology. 122:527
Autor:
Amos Baruch, Whittemore G. Tingley, Jin Y. Jin, Maya Leabman, D. Russell Wada, Kun Peng, Nageshwar Budha, John D. Davis
RG7652 is a fully humanized monoclonal antibody targeting human PCSK9, a regulator of serum low density lipoprotein cholesterol (LDLc) levels. RG7652 prevents degradation of the hepatic LDLc receptors by blocking PCSK9 binding and thereby resulting i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d61c73da86d9fd10cb951ea4270ded
https://europepmc.org/articles/PMC4476990/
https://europepmc.org/articles/PMC4476990/
Autor:
Kimihiko Kameyama, Michael D. Ehlers, Whittemore G. Tingley, Clark T. Riley, Richard L. Huganir, Carol A. Doherty, Janine Ptak
Publikováno v:
Journal of Biological Chemistry. 272:5157-5166
Modulation of N-methyl-D-aspartate receptors in the brain by protein phosphorylation may play a central role in the regulation of synaptic plasticity. To examine the phosphorylation of the NR1 subunit of N-methyl-D-aspartate receptors in situ, we hav
Publikováno v:
Science. 269:1734-1737
NMDA (N-methyl-D-aspartate) receptors are selectively localized at the postsynaptic membrane of excitatory synapses in the mammalian brain. The molecular mechanisms underlying this localization were investigated by expressing the NR1 subunit of the N
Publikováno v:
Current Opinion in Neurobiology. 4:383-388
The recent findings that glutamate receptors are phosphorylated and functionally modulated by protein kinases has provided evidence that phosphorylation of these receptors may play a critical role in mechanisms of synaptic plasticity.
Autor:
Steven A. Rosenberg, Robert S. Schwartz, Stephen G. Ellis, Susan E. Daniels, James A. Wingrove, Whittemore G. Tingley, William E. Kraus, Eric J. Topol, Philip Beineke, Ron Waksman, Michael Elashoff, Szilard Voros, John A. McPherson, Alexandra J. Lansky, Geoffrey S. Ginsburg, Naheem Tahirkheli
Publikováno v:
BMC Medical Genomics
BMC Medical Genomics, Vol 4, Iss 1, p 26 (2011)
BMC Medical Genomics, Vol 4, Iss 1, p 26 (2011)
Background Alterations in gene expression in peripheral blood cells have been shown to be sensitive to the presence and extent of coronary artery disease (CAD). A non-invasive blood test that could reliably assess obstructive CAD likelihood would hav
Autor:
Eberhard Grube, Whittemore G. Tingley, Michael Elashoff, L. Kristin Newby, Geoffrey S. Ginsburg, William E. Kraus, Susan E. Daniels, Lutz Buellesfeld, Steven Rosenberg, James A. Wingrove, Amy J. Sehnert
Publikováno v:
Circulation. Cardiovascular genetics. 1(1)
Background— The molecular pathophysiology of coronary artery disease (CAD) includes cytokine release and a localized inflammatory response within the vessel wall. The extent to which CAD and its severity is reflected by gene expression in circulati
Autor:
Serina A. Neumann, Matthew F. Muldoon, Robert E. Ferrell, Eloise Peet, Stephen B. Manuck, J. Richard Jennings, Whittemore G. Tingley, Bruce R. Conklin, Catherine J. Shrader
Cardiovascular disease is a leading cause of death in the U.S. with sudden cardiac death (SCD) taking an estimated 300,000 to 460,000 adult lives each year in the U.S (Zheng et al., 2001; de Vreede-Swagemakers et al., 1997; 2007). Unfortunately, SCD
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b9bee5c45e89d3e2935aaffa131513b
https://europepmc.org/articles/PMC2890278/
https://europepmc.org/articles/PMC2890278/